title: Identification and evolution of drug efflux pump in clinical Enterobacter aerogenes strains isolated in 1995 and 2003.
abstract: BACKGROUND
  The high mortality impact of infectious diseases will increase due to accelerated evolution of antibiotic resistance in important human pathogens. Development of antibiotic resistance is a evolutionary process inducing the erosion of the effectiveness of our arsenal of antibiotics. Resistance is not necessarily limited to a single class of antibacterial agents but may affect many unrelated compounds; this is termed 'multidrug resistance' (MDR). The major mechanism of MDR is the active expulsion of drugs by bacterial pumps; the treatment of gram negative bacterial infections is compromised due to resistance mechanisms including the expression of efflux pumps that actively expel various usual antibiotics (beta-lactams, quinolones, ...).
  
  
  RESULTS
  Enterobacter aerogenes has emerged among Enterobacteriaceae associated hospital infections during the last twenty years due to its faculty of adaptation to antibiotic stresses. Clinical isolates of E. aerogenes belonging to two strain collections isolated in 1995 and 2003 respectively, were screened to assess the involvement of efflux pumps in antibiotic resistance. Drug susceptibility assays were performed on all bacterial isolates and an efflux pump inhibitor (PAbetaN) previously characterized allowed to decipher the role of efflux in the resistance. Accumulation of labelled chloramphenicol was monitored in the presence of an energy poison to determine the involvement of active efflux on the antibiotic intracellular concentrations. The presence of the PAbetaN-susceptible efflux system was also identified in resistant E. aerogenes strains.
  
  
  CONCLUSIONS
  For the first time a noticeable increase in clinical isolates containing an efflux mechanism susceptible to pump inhibitor is report within an 8 year period. After the emergence of extended spectrum beta-lactamases in E. aerogenes and the recent characterisation of porin mutations in clinical isolates, this study describing an increase in inhibitor-susceptible efflux throws light on a new step in the evolution of mechanism in E. aerogenes.
authors.affiliation: UMR-MD1, IFR 48, Facultés de Médecine et de Pharmacie, Marseille, France.
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Chevalier
authors.forename: Céline
authors.initials: C
authors.lastname: Mulfinger
authors.forename: Eric
authors.initials: E
authors.lastname: Garnotel
authors.forename: Pierre
authors.initials: P
authors.lastname: Nicolas
authors.forename: Anne
authors.initials: A
authors.lastname: Davin-Régli
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Pagès
mesh_terms: D015373:Bacterial Typing Techniques; D002701:Chloramphenicol / Q000378:metabolism; D018432:Drug Resistance, Multiple; D024901:Drug Resistance, Multiple, Bacterial / Q000187:drug effects / Q000235:genetics*; D021902:Enterobacter aerogenes / Q000235:genetics* / Q000378:metabolism*; D004756:Enterobacteriaceae Infections / Q000453:epidemiology* / Q000235:genetics; D029968:Escherichia coli Proteins / Q000378:metabolism; D006801:Humans; D008074:Lipoproteins / Q000378:metabolism; D026901:Membrane Transport Proteins / Q000378:metabolism; D008826:Microbial Sensitivity Tests; D008954:Models, Biological; D009154:Mutation; D018272:Porins / Q000235:genetics; D013045:Species Specificity; D013997:Time Factors; D001618:beta-Lactamases / Q000378:metabolism
chemical_list: C083497:AcrA protein, E coli; D029968:Escherichia coli Proteins; D008074:Lipoproteins; D026901:Membrane Transport Proteins; D018272:Porins; D002701:Chloramphenicol; D001618:beta-Lactamases
references.citation: Clin Microbiol Rev. 2006 Apr;19(2):382-402
references.pmid: 16614254
references.citation: J Clin Microbiol. 1996 Sep;34(9):2163-9
references.pmid: 8862578
references.citation: J Antimicrob Chemother. 2006 Dec;58(6):1154-9
references.pmid: 17023497
references.citation: Antimicrob Agents Chemother. 2005 Apr;49(4):1354-8
references.pmid: 15793111
references.citation: Biochem Biophys Res Commun. 2005 Mar 25;328(4):1113-8
references.pmid: 15707992
references.citation: Nat Rev Microbiol. 2006 Aug;4(8):629-36
references.pmid: 16845433
references.citation: Antimicrob Agents Chemother. 2002 Apr;46(4):1128-31
references.pmid: 11897606
references.citation: Biochem Biophys Res Commun. 2002 May 24;293(5):1370-3
references.pmid: 12054665
references.citation: Antimicrob Agents Chemother. 2002 Dec;46(12):3984-6
references.pmid: 12435706
references.citation: FEMS Microbiol Lett. 1996 May 15;139(1):1-10
references.pmid: 8647368
references.citation: Lancet Infect Dis. 2003 Dec;3(12):794-803
references.pmid: 14652205
references.citation: J Antimicrob Chemother. 2006 Aug;58(2):423-7
references.pmid: 16735418
references.citation: Drug Resist Updat. 2003 Feb;6(1):9-13
references.pmid: 12654283
references.citation: J Antimicrob Chemother. 2007 Dec;60(6):1370-4
references.pmid: 17913717
references.citation: Antimicrob Agents Chemother. 2003 Nov;47(11):3506-14
references.pmid: 14576109
references.citation: Antimicrob Agents Chemother. 2006 Jan;50(1):38-42
references.pmid: 16377664
references.citation: PLoS One. 2007 Apr 11;2(4):e365
references.pmid: 17426813
references.citation: J Hosp Infect. 2002 Jul;51(3):221-5
references.pmid: 12144802
references.citation: Biochem Biophys Res Commun. 2003 Feb 21;301(4):985-90
references.pmid: 12589810
references.citation: Antimicrob Agents Chemother. 1996 Dec;40(12):2854-8
references.pmid: 9124854
references.citation: Trends Mol Med. 2005 Aug;11(8):382-9
references.pmid: 15996519
references.citation: Pharmacotherapy. 2003 Jul;23(7):916-24
references.pmid: 12885104
references.citation: Lancet. 2005 Feb 12-18;365(9459):579-87
references.pmid: 15708101
references.citation: J Clin Microbiol. 2002 Apr;40(4):1237-43
references.pmid: 11923338
references.citation: J Antimicrob Chemother. 2005 Jul;56(1):20-51
references.pmid: 15914491
references.citation: J Clin Microbiol. 2000 Mar;38(3):1048-52
references.pmid: 10698994
references.citation: J Antimicrob Chemother. 2004 Mar;53(3):544-5
references.pmid: 14762057
references.citation: Nat Rev Microbiol. 2006 Jan;4(1):57-66
references.pmid: 16357861
references.citation: J Antimicrob Chemother. 2006 Sep;58(3):673-7
references.pmid: 16870650
references.citation: Biochem Biophys Res Commun. 2004 May 7;317(3):851-6
references.pmid: 15081418
references.citation: Antimicrob Agents Chemother. 2006 May;50(5):1633-41
references.pmid: 16641429
references.citation: J Infect Dis. 2007 Dec 15;196(12):1804-12
references.pmid: 18190261
references.citation: J Clin Microbiol. 2004 Jun;42(6):2701-6
references.pmid: 15184455
references.citation: Antimicrob Agents Chemother. 2003 Oct;47(10):3089-98
references.pmid: 14506014
references.citation: Cell Microbiol. 2006 May;8(5):847-56
references.pmid: 16611233
references.citation: Curr Microbiol. 1999 Aug;39(2):68-72
references.pmid: 10398829
references.citation: Antimicrob Agents Chemother. 2003 May;47(5):1555-9
references.pmid: 12709321
references.citation: J Clin Microbiol. 2004 Aug;42(8):3805-8
references.pmid: 15297534
references.citation: Biochem Pharmacol. 2006 Mar 30;71(7):910-8
references.pmid: 16427026
references.citation: J Hosp Infect. 2007 Apr;65(4):372-4
references.pmid: 17275960
references.citation: Antimicrob Agents Chemother. 2001 Jan;45(1):105-16
references.pmid: 11120952
references.citation: Antimicrob Agents Chemother. 2002 Aug;46(8):2640-3
references.pmid: 12121946
references.citation: J Antimicrob Chemother. 2006 Jun;57(6):1223-6
references.pmid: 16606635
references.citation: J Clin Microbiol. 1995 Sep;33(9):2233-9
references.pmid: 7494007
references.citation: Microbiology (Reading). 1998 Nov;144 ( Pt 11):3003-3009
references.pmid: 9846735
references.citation: Antimicrob Agents Chemother. 2005 Jul;49(7):2965-71
references.pmid: 15980376
references.citation: Antimicrob Agents Chemother. 2004 Sep;48(9):3621-4
references.pmid: 15328143
references.citation: J Clin Microbiol. 1996 Jun;34(6):1474-80
references.pmid: 8735101
references.citation: J Clin Microbiol. 1999 Jul;37(7):2165-9
references.pmid: 10364580
references.citation: J Clin Microbiol. 2001 Mar;39(3):889-96
references.pmid: 11230400